Latest news
Loading news…
3P Biopharmaceuticals
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring). Noáin, Navarra, Spain Founded 2006 251-500 employees For Profit
3P Biopharmaceuticals is specialized in the development and manufacture of biologics and cell therapy products.
3P Biopharmaceuticals was acquired by Keensight Capital in 2019.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
5
Patents
2
9 trademarks
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 28
- Active products
- 22
- Patents granted
- 2
- Trademarks
- 9
- Top patent class
- Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering
- IT spend
- $2M
Company Info
- Founded
- 2006
- Employees
- 251-500
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- News articles
- 13
- Events
- 2
- HQ
- Noáin, Navarra, Spain
- Region
- European Union (EU), Europe, Middle East, and Africa (EMEA)
- Exit date
- Jul 23, 2019
Signals & Scores
- Heat score
- Low
- Trend (7d)
- -0.1
- Trend (30d)
- -0.4
- Trend (90d)
- 3.3
5
professional contacts at 3P Biopharmaceuticals
Contact execs at 3P Biopharmaceuticals →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to 3P Biopharmaceuticals
Loading news…
FAQs about 3P Biopharmaceuticals
People who checked this page also checked these
Browse the full Acquirezy directory.